SCHEMBL3708699

SCHEMBL3708699

O=C(NCc1cccc(C(F)(F)F)c1)c1nc2c(C(F)(F)F)cc(-c3ccco3)cn2c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
MEN1 O00255 1/20 0.45
PLA2G1B P04054 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
GAA P10253 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ATG4B Q9Y4P1 1/20 0.45
SCD5 Q86SK9 1/20 0.44
CCR1 P32246 8/20 0.44
MLYCD O95822 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
ADA P00813 1/20 0.41
MAPK1 P28482 1/20 0.41
ADORA3 P0DMS8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3702560 0.92 ADORA2A (0.46) PKMRXFP1MEN1KMT2AADA
SCHEMBL3696233 0.91 PKM (0.49) PKMRXFP1MEN1GAAKMT2A
SCHEMBL3701552 0.89 ABCB1 (0.45) PKMRXFP1MAPK1ADORA3ADORA2A
SCHEMBL3703954 0.89 ADORA3 (0.49) PKMRXFP1MEN1CYP1A2CYP3A4
SCHEMBL7495068 0.88 PKM (0.46) PKMRXFP1MEN1CYP1A2CYP2C19
SCHEMBL7490135 0.88 ALDH1A1 (0.51) PKMRXFP1MEN1KMT2ASCD5
SCHEMBL7490205 0.87 RXFP1 (0.45) PKMRXFP1MEN1CYP1A2CYP3A4
SCHEMBL7490436 0.87 ALDH1A1 (0.48) PKMRXFP1MEN1CYP1A2CYP3A4
SCHEMBL3690016 0.86 PKM (0.42) PKMRXFP1MEN1GAAKMT2A
SCHEMBL3706824 0.86 PKM (0.44) PKMRXFP1MEN1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
WO-2009023179-A2 NITROGEN CONTAINING BICYCLIC CHEMICAL ENTITIES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2009-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections OAT, HAVCR2, CPS1 PKM 2286/4885RXFP1 4676/4885MEN1 4257/4885
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections OAT, HAVCR2, CPS1 PKM 2286/4885RXFP1 4676/4885MEN1 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.